To The Moon

$UnitedHealth(UNH)$  Few would have expected UnitedHealth Group (UNH), a long-time Wall Street darling and a symbol of stability, to be among the worst-performing large-cap stocks this year. Yet here we are in 2025, and the stock has collapsed by over 52% year-to-date — a shocking reversal for what was once considered a defensive powerhouse. The big question now? Has UNH hit bottom, or is more pain to come? What's Driving the Meltdown? The selloff didn’t happen in a vacuum. Investors have been spooked by a combination of real business headwinds and shifting macro trends. Among the most pressing concerns: Rising Medical Costs: Post-pandemic, there's been a surge in elective procedures, hospital visits, and utilization

$Figma(FIG)$ Figma just took a brutal 18% nosedive after its long-anticipated public debut. What was supposed to be a moment of triumph quickly turned into a sharp correction. Investors who had been riding the IPO hype now face a sobering reality: high valuation + zero profits = high volatility. The drop is catching attention, not only because of the size, but also the timing. Figma’s option market is now live, and with it comes an entirely new playbook. The ability to short, hedge, or speculate on volatility is no longer limited to just stock sales — traders are now armed with puts and calls. And guess what? Some are clearly betting on more downside. Let’s break this down. 1. IPO Hangover? Figma came to market with strong design community support

Big tech chips are back in the spotlight! Both $AMD and $SMCI are set to report earnings on August 5, but expectations couldn't be more different. 🔸 $AMD is forecasted to post Q2 revenue of $7.43B, up 27% YoY — impressive growth! But net income may slide to $796.6M (from $1.26B last year), reflecting margin compression despite topline expansion. 🔸 $SMCI faces a 29% plunge in EPS to $0.45, but revenue is expected to grow 13% YoY to $5.98B — possibly driven by AI server demand. 💡 Investors now face a dilemma: ➡️ High growth, falling profit (AMD) or ➡️ Shrinking margins, solid revenue momentum (SMCI)? Chip stocks have been riding the AI wave, but will earnings disappoint and trigger a short-term pullback? 📉 Strategy Tip: Consider selling premium via iron condors or vertical spreads to hedge v

$Walt Disney(DIS)$ is scheduled to report its fiscal Q3 2025 earnings before the market opens on Wednesday, August 6, 2025. This report is a critical update on the company's progress under CEO Bob Iger's turnaround plan, which focuses on profitability in streaming, growth in its Parks segment, and a strong content slate. Revenue: The consensus among analysts is that Disney will report revenues of approximately $23.76 billion, a modest year-over-year increase. EPS (Earnings Per Share): The forecast for adjusted earnings per share (EPS) is around $1.47. This represents an increase from the same quarter last year, a positive sign of the company's path to profitability. Summary of The Walt Disney Co. (DIS) Fiscal Q2 2025 Earnings The Walt Disney Co. de

Overall Market Overview Markets across the globe rallied on August 4, 2025, as investors shrugged off prior session losses sparked by fresh US tariffs and economic worries. Confidence returned as rate-cut expectations gained traction and sectors like banking led recoveries. The Dow surged 585 points, while Europe and Asia also saw broad gains. US Markets: Reclaiming Ground After Panic Sell-Off Wall Street rebounded strongly, led by renewed optimism after a sharp pullback. The Dow Jones $DJIA(.DJI)$  rose 1.3% to 44,173.64, the S&P 500 $S&P 500(.SPX)$  gained 1.4% to 6,329.94, and the Nasdaq

$UnitedHealth(UNH)$  I am observing with concern the steep decline in UnitedHealth Group's stock, which has dropped from around $600 in April of this year to its current price near $240. The fact that it has lost 52% year-to-date is alarming, and the speculation that UNH may head to $160 adds to the uncertainty. This significant downturn has caught my attention, especially given the company's previous strength. I have reviewed the chart I attached below, and the monthly candlestick pattern shows an extremely bearish trend. The stock remains well below the EMA200 (green coloured line), a key indicator for me, suggesting that the downward momentum is far from over. This technical analysis reinforces my cautious stance o

For me, my main target right now is $Palantir Technologies Inc.(PLTR)$ . After last night’s impressive earnings release, the stock surged. Palantir continues to show strong momentum in both government and commercial segments, and their expanding role in AI integration is a major driver. The company is proving it can deliver both innovation and profitability, which gives me strong conviction in its long-term growth potential. On the Singapore front, I’m also focusing on $CapLand IntCom T(C38U.SI)$ . The REIT reported a solid 3.5% rise in H1 DPU, driven by contributions from ION Orchard. Its upcoming acquisition of a 55% stake in CapitaSpring is expected to further boost DPU, which is encouraging for i

$UnitedHealth(UNH)$   ​ Overview: What’s Driving the Decline? Massive drawdown: UNH shares plunged from approximately $600 in mid‑April 2025 to around $241–$260, a decline of ~55–60% . Catalysts: A combination of dramatically rising medical claims, underfunded Medicare Advantage programs (resulting in an 89.4% medical cost ratio)—and regulatory and DOJ scrutiny over billing practices—triggered sharp earnings downgrades and leadership reshuffles . Analyst reviews: Bernstein recently lowered its 12-month target to $337, while UBS maintains a $330 target, and average consensus across 23–24 analysts ranges from $320–$405, signaling potential 30–70% upside if recovery unfolds . Valuation: Current forward P/E sits at ~

$Netflix(NFLX)$ $Taiwan Semiconductor Manufacturing(TSM)$ Thursday packs a punch with June retail sales data and earnings from Netflix and TSMC. Retail sales, tracking consumer spending (70% of U.S. GDP), are expected to inch up 0.4% from May’s 0.3%, but inflation (3.7% CPI) could mask real weakness—adjusted for price hikes, growth may be flat. Auto sales (up 2%) and e-commerce (up 5%) lead, while apparel lags (down 1%). Netflix aims for 2.5 million new subscribers (total: 235 million), banking on hits like Stranger Things Season 5; revenue’s pegged at $9.6 billion, up 7%. TSMC, the chip kingpin, forecasts $19.5 billion in revenue (up 10%), riding AI and smartphone demand. Details: Tech analyst John Smith

$Figma(FIG)$ Here’s a formal, professional assessment of Figma (FIG) following its recent IPO surge: --- ​ Key Developments IPO breakthrough: Figma priced its offering at $33 per share and opened trading on July 31, 2025, under the ticker FIG, raising ~$1.2 billion. The stock closed its first day at $115.50, up ~250% from the IPO price, valuing the company around $56–59 billion . Back to Earth: After that initial spike, shares fell roughly 20–23%, sliding toward $92–98 on follow‑up trading days . --- ​ Has the Rally Ended? Momentum drivers: Figma’s exceptional debut was driven by pent-up demand for high-profile tech IPOs—much like Circle’s earlier this year. This IPO's upsizing enabled strong first-day momentum . The enthusiasm, however, largely r

Tesla’s Road to Glory: Why TSLA Is Set to Soar Through 2027 Tesla ($Tesla Motors(TSLA)$ ) trades at $310.22, up a modest 0.31% in the last 24 hours. Yet, beneath this calm surface lies a stock primed for a remarkable ascent, fueled by Elon Musk’s renewed commitment and Tesla’s bold vision. With a groundbreaking compensation package tying Musk to the company until 2027, the stage is set for a bullish rally that could see TSLA double in value. Here’s why investors should buckle up for this electrifying journey. Musk’s Million-Share Motivation Tesla’s recent approval of a 96 million-share award for Elon Musk, priced at $23.34 per share and vesting through August 3, 2027, is a game-changer. This move, greenlit by a special committee in early 2025, ali

$UnitedHealth(UNH)$ UnitedHealth Group (UNH): A 52% Drop Hides a Golden Opportunity UnitedHealth Group (UNH) trades at $241.20, up a modest 0.09% in the last 24 hours, following a staggering 52% year-to-date decline from its April peak near $600. While some predict a further drop to $160, this steep fall is not a death knell but a rare chance to buy a healthcare giant at a discount. With its robust fundamentals and signs of stabilization, UNH is poised for a strong recovery. Here’s why investors should see this as a bullish turning point. The Dip That Defies the Narrative UNH’s 52% drop from $600 to $241.20 has sparked panic, with some eyeing a potential slide to $160. However, this decline reflects broader market volatility and sector-specific pre